{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:25:12Z","timestamp":1786465512920,"version":"build-2736575974"},"reference-count":96,"publisher":"American Chemical Society (ACS)","issue":"31","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100004605","name":"Zhengzhou University","doi-asserted-by":"publisher","award":["35220725"],"award-info":[{"award-number":["35220725"]}],"id":[{"id":"10.13039\/501100004605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (NSFC)","doi-asserted-by":"crossref","award":["22406173"],"award-info":[{"award-number":["22406173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (NSFC)","doi-asserted-by":"crossref","award":["42407574"],"award-info":[{"award-number":["42407574"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Education Laboratory for Earth Surface Processes, Peking University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiovascular diseases driven by atherosclerosis are a leading global cause of mortality. However, currently identified risk chemicals account for only a small fraction of the environmental chemical burden contributing to atherosclerosis. To address this gap, we established a multi-source prioritization framework to identify pro-atherogenic chemicals among 6346 exogenous compounds predicted in human blood. The framework integrates bioactivity data for atherosclerosis-relevant nuclear receptors, including peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3), liver X receptor \u03b1 (LXR\u03b1), farnesoid X receptor (FXR), and pregnane X receptor (PXR), with physicochemical properties and predicted blood concentrations of the compounds. Experimental validation identified eight chemicals with specific nuclear receptor modulating activity. Notably, six of these chemicals significantly promoted macrophage foam cell formation, a hallmark and initiating event in atherosclerosis. Mechanistic investigations demonstrated that antagonists of PPAR\u03b3 and\/or LXR\u03b1, including tetrabromobisphenol A bis(2-hydroxyethyl) ether (TBBPA-BHEE), 3,5-dichlorosalicyl-3,4-dichloroanilide (TCSA), 4,4\u2032,4\u2033-ethane-1,1,1-triyltriphenol (THPE), and lopinavir, disrupted cholesterol homeostasis, potentially through inhibition of LXR\u03b1-mediated efflux. In parallel, PXR agonists, 2,2\u2032,6,6\u2032-tetrachlorobisphenol A (TCBPA) and 4,4\u2032-methylenebis(2,6-diethylaniline) (MDEA), promoted lipid accumulation by enhancing cholesterol uptake. This study provides a mechanistically anchored, high-throughput strategy for identifying potential environmental contributors to cardiovascular disease, revealing previously unrecognized pro-atherogenic chemicals and their molecular mechanisms.<\/jats:p>","DOI":"10.1021\/acs.est.6c06583","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:09:53Z","timestamp":1785848993000},"page":"21596-21608","source":"Crossref","is-referenced-by-count":0,"title":["From Exposome-Scale\nScreening to Foam Cell Formation:\nIdentifying Environmental Chemicals with Atherogenic Potential via\nNuclear Receptor Perturbation"],"prefix":"10.1021","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4784-3753","authenticated-orcid":true,"given":"Xinming","family":"Shen","sequence":"first","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450001"]},{"name":"Peking University , , ,","place":["Beijing, China, 100871"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajun","family":"Zhen","sequence":"additional","affiliation":[{"name":"Peking University , , ,","place":["Beijing, China, 100871"]},{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Peking University , , ,","place":["Beijing, China, 100871"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9268-403X","authenticated-orcid":true,"given":"Yatai","family":"Li","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9824-3534","authenticated-orcid":true,"given":"Qihong","family":"Deng","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"10258","key":"2026081110085328400_cit1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369\ndiseases and injuries in 204 countries and territories, 1990\u20132019:\na systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"2026081110085328400_cit2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4070\/kcj.2010.40.1.1","article-title":"Atherosclerotic\ncardiovascular disease beginning in childhood","volume":"40","author":"Hong","year":"2010","journal-title":"Korean Circ. J."},{"issue":"3","key":"2026081110085328400_cit3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41569-023-00931-w","article-title":"Effects of lifestyle factors on leukocytes\nin cardiovascular health and disease","volume":"21","author":"Janssen","year":"2024","journal-title":"Nat. Rev.\nCardiol."},{"issue":"10","key":"2026081110085328400_cit4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41569-023-00873-3","article-title":"The contribution of the exposome to the burden of cardiovascular\ndisease","volume":"20","author":"Mu\u0308nzel","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"2026081110085328400_cit5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1021\/envhealth.4c00166","article-title":"Association\nof per- and polyfluoroalkyl substance\nexposure with coronary stenosis and prognosis in acute coronary syndrome","volume":"3","author":"Li","year":"2025","journal-title":"Environ. Health"},{"issue":"3","key":"2026081110085328400_cit6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1021\/envhealth.3c00155","article-title":"Mediating role of glucose-lipid metabolism in the association\nbetween the increased risk of coronary heart disease and exposure\nto organophosphate esters, phthalates, and polycyclic aromatic hydrocarbons","volume":"2","author":"Zhang","year":"2024","journal-title":"Environ. Health"},{"issue":"48","key":"2026081110085328400_cit7","doi-asserted-by":"publisher","first-page":"19374","DOI":"10.1021\/acs.est.3c06029","article-title":"Relationships\nof liver X receptor antagonists and atherosclerosis in drinking water\nfrom six Chinese major cities","volume":"57","author":"Shen","year":"2023","journal-title":"Environ. Sci.\nTechnol."},{"issue":"10119","key":"2026081110085328400_cit8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0140-6736(17)32345-0","article-title":"The Lancet Commission\non pollution and health","volume":"391","author":"Landrigan","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"2026081110085328400_cit9","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1289\/ehp.1510456","article-title":"Prioritizing environmental\nchemicals for obesity and diabetes outcomes research: a screening\napproach using Toxcast high-throughput data","volume":"124","author":"Auerbach","year":"2016","journal-title":"Environ. Health Perspect."},{"issue":"5","key":"2026081110085328400_cit10","doi-asserted-by":"publisher","DOI":"10.1289\/EHP6779","article-title":"On the\nutility of Toxcast-based predictive models to evaluate potential metabolic\ndisruption by environmental chemicals","volume":"130","author":"Filer","year":"2022","journal-title":"Environ.\nHealth Perspect."},{"issue":"5548","key":"2026081110085328400_cit11","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","article-title":"Nuclear\nreceptors and lipid physiology: opening the X-files","volume":"294","author":"Chawla","year":"2001","journal-title":"Science"},{"issue":"1","key":"2026081110085328400_cit12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41392-025-02270-3","article-title":"Nuclear receptors in health and disease: signaling\npathways, biological functions and pharmaceutical interventions","volume":"10","author":"Jin","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"2026081110085328400_cit13","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1021\/tx500345j","article-title":"Defining molecular\ninitiating events in the adverse outcome pathway framework for risk\nassessment","volume":"27","author":"Allen","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"12","key":"2026081110085328400_cit14","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular\nfunctions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"2026081110085328400_cit15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nrd4280","article-title":"Liver X receptors in lipid metabolism: opportunities\nfor drug discovery","volume":"13","author":"Hong","year":"2014","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"8","key":"2026081110085328400_cit16","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/ATVBAHA.109.197897","article-title":"A Role of the Bile\nSalt Receptor FXR in Atherosclerosis","volume":"30","author":"Hageman","year":"2010","journal-title":"Arterioscler.\nThromb. Vasc. Biol."},{"issue":"4","key":"2026081110085328400_cit17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm3312","article-title":"Transcriptional integration\nof metabolism by the nuclear\nsterol-activated receptors LXR and FXR","volume":"13","author":"Calkin","year":"2012","journal-title":"Nat.\nRev. Mol. Cell Biol."},{"issue":"9","key":"2026081110085328400_cit18","doi-asserted-by":"publisher","first-page":"bvaf119","DOI":"10.1210\/jendso\/bvaf119","article-title":"Physiological Functions\nand Pathological Roles of PXR","volume":"9","author":"Ikeda","year":"2025","journal-title":"J. Endocr. Soc."},{"issue":"8","key":"2026081110085328400_cit19","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1161\/01.ATV.0000173413.31789.1a","article-title":"Conditional\nknockout\nof macrophage ppar\u03b3 increases atherosclerosis in C57BL\/6 and\nlow-density lipoprotein receptor-deficient mice","volume":"25","author":"Babaev","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"18","key":"2026081110085328400_cit20","doi-asserted-by":"publisher","first-page":"11896","DOI":"10.1073\/pnas.182199799","article-title":"Identification of macrophage\nliver X receptors as inhibitors of atherosclerosis","volume":"99","author":"Tangirala","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"2026081110085328400_cit21","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1194\/jlr.M500390-JLR200","article-title":"Loss of functional\nfarnesoid X receptor increases atherosclerotic lesions in apolipoprotein\nE-deficient mice","volume":"46","author":"Hanniman","year":"2005","journal-title":"J. Lipid. Res."},{"issue":"10","key":"2026081110085328400_cit22","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1194\/jlr.M800608-JLR200","article-title":"Activation of PXR\ninduces hypercholesterolemia in wild-type and accelerates atherosclerosis\nin apoE deficient mice","volume":"50","author":"Zhou","year":"2009","journal-title":"J. Lipid. Res."},{"issue":"4","key":"2026081110085328400_cit23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1172\/JCI10370","article-title":"Peroxisome\nproliferator-activated receptor gamma ligands\ninhibit development of atherosclerosis in LDL receptor-deficient mice","volume":"106","author":"Li","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"11","key":"2026081110085328400_cit24","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1073\/pnas.0711875105","article-title":"PPAR\u03b4 regulates\nmultiple proinflammatory pathways to suppress atherosclerosis","volume":"105","author":"Barish","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"2026081110085328400_cit25","doi-asserted-by":"publisher","first-page":"7604","DOI":"10.1073\/pnas.112059299","article-title":"Synthetic LXR ligand\ninhibits the development of atherosclerosis in mice","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"2026081110085328400_cit26","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1194\/jlr.M800619-JLR200","article-title":"Activation of farnesoid\nX receptor prevents atherosclerotic\nlesion formation in LDLR\u2013\/\u2013 and apoE\u2013\/\u2013\nmice","volume":"50","author":"Hartman","year":"2009","journal-title":"J. Lipid. Res."},{"issue":"9","key":"2026081110085328400_cit27","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1194\/jlr.M017376","article-title":"Deficiency of PXR decreases atherosclerosis\nin apoE-deficient mice","volume":"52","author":"Sui","year":"2011","journal-title":"J. Lipid. Res."},{"issue":"3","key":"2026081110085328400_cit28","doi-asserted-by":"publisher","first-page":"37009","DOI":"10.1289\/EHP11305","article-title":"HExpPredict: in vivo exposure prediction\nof human blood exposome using a random forest model and its application\nin chemical risk prioritization","volume":"131","author":"Zhao","year":"2023","journal-title":"Environ. Health\nPerspect."},{"issue":"5865","key":"2026081110085328400_cit29","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1126\/science.1154619","article-title":"Toxicology. Transforming environmental\nhealth protection","volume":"319","author":"Collins","year":"2008","journal-title":"Science"},{"issue":"2\u20134","key":"2026081110085328400_cit30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/10937404.2010.483176","article-title":"Toxicity testing in\nthe 21st century: a vision and\na strategy","volume":"13","author":"Krewski","year":"2010","journal-title":"Journal of Toxicology and Environmental\nHealth. Part B, Critical Reviews"},{"issue":"3","key":"2026081110085328400_cit31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the\npathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"issue":"1","key":"2026081110085328400_cit32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nrcardio.2014.173","article-title":"Macrophage subsets in atherosclerosis","volume":"12","author":"Chinetti-Gbaguidi","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"issue":"11","key":"2026081110085328400_cit33","doi-asserted-by":"publisher","first-page":"117003","DOI":"10.1289\/EHP5039","article-title":"Screening of house dust from Chinese homes for chemicals\nwith liver X receptors binding activities and characterization of\natherosclerotic activity using an in vitro macrophage\ncell line and ApoE\u2013\/\u2013 mice","volume":"127","author":"Hu","year":"2019","journal-title":"Environ. Health Perspect."},{"issue":"7855","key":"2026081110085328400_cit34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing\nlandscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"2026081110085328400_cit35","unstructured":"U.S. Environmental Protection Agency (EPA).\n          .  ToxCast Assay Endpoints\nList; EPA: Washington, D.C., 2025; https:\/\/comptox.epa.gov\/dashboard\/assay-endpoints (accessed May 6, 2025)."},{"issue":"4","key":"2026081110085328400_cit36","doi-asserted-by":"publisher","first-page":"47014","DOI":"10.1289\/EHP7722","article-title":"Risk-based chemical\nranking and generating a prioritized human exposome database","volume":"129","author":"Zhao","year":"2021","journal-title":"Environ. Health Perspect."},{"key":"2026081110085328400_cit37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.coph.2014.09.021","article-title":"Test driving\nToxCast: endocrine profiling for 1858 chemicals included in phase\nII","volume":"19","author":"Filer","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"issue":"31","key":"2026081110085328400_cit38","doi-asserted-by":"publisher","first-page":"11656","DOI":"10.1021\/acs.est.3c04159","article-title":"New perspective to understand and prioritize\nthe ecological impacts of organophosphate esters and transformation\nproducts in urban stormwater and sewage effluents","volume":"57","author":"Lao","year":"2023","journal-title":"Environ. Sci. Technol."},{"issue":"32","key":"2026081110085328400_cit39","doi-asserted-by":"publisher","first-page":"14506","DOI":"10.1021\/acs.est.4c04891","article-title":"Integration of nontarget\nscreening and qspr models to identify novel organophosphate esters\nof high priority in aquatic environment","volume":"58","author":"Zhang","year":"2024","journal-title":"Environ.\nSci. Technol."},{"issue":"15","key":"2026081110085328400_cit40","doi-asserted-by":"publisher","first-page":"10681","DOI":"10.1021\/acs.est.2c00966","article-title":"Occurrence and ecological impact of chemical mixtures in a semiclosed\nsea by suspect screening analysis","volume":"56","author":"Feng","year":"2022","journal-title":"Environ.\nSci. Technol."},{"issue":"12","key":"2026081110085328400_cit41","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1289\/ehp.1002180","article-title":"Endocrine profiling\nand prioritization of environmental chemicals using ToxCast data","volume":"118","author":"Reif","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"2026081110085328400_cit42","doi-asserted-by":"publisher","first-page":"115011","DOI":"10.1016\/j.ecoenv.2023.115011","article-title":"Benzo[a]pyrene and\na high-fat diet induce aortic injury and promote\nlow-density lipoprotein accumulation in the endothelium","volume":"259","author":"Duan","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"1","key":"2026081110085328400_cit43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12989-022-00482-x","article-title":"Aryl hydrocarbon\nreceptor\nactivation-mediated vascular toxicity of ambient fine particulate\nmatter: contribution of polycyclic aromatic hydrocarbons and osteopontin\nas a biomarker","volume":"19","author":"Ho","year":"2022","journal-title":"Part. Fibre. Toxicol."},{"issue":"1","key":"2026081110085328400_cit44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0002-9440(10)63101-X","article-title":"Chronic\nexposure to the carcinogenic compound benzo[a]pyrene\ninduces larger and phenotypically different atherosclerotic plaques\nin ApoE-knockout mice","volume":"164","author":"Curfs","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"2","key":"2026081110085328400_cit45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000492","article-title":"Bisphenol A increases atherosclerosis\nin pregnane X receptor-humanized ApoE deficient mice","volume":"3","author":"Sui","year":"2014","journal-title":"J. Am. Heart. Assoc."},{"issue":"1","key":"2026081110085328400_cit46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/ATVBAHA.125.322198","article-title":"Distinct roles\nof PPARs in atherosclerosis","volume":"46","author":"Wang","year":"2026","journal-title":"Arterioscler. Thromb.\nVasc. Biol."},{"issue":"6","key":"2026081110085328400_cit47","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1161\/ATVBAHA.125.322448","article-title":"Inhibition\nof LXR signaling in human foam cells impairs macrophage-to-endothelial\ncell cross talk and promotes endothelial cell inflammation","volume":"45","author":"Leleu","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"2026081110085328400_cit48","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/00005344-200001000-00020","article-title":"Effects\nof troglitazone\non collagen accumulation and distensibility of aortic wall in prestage\nof non-insulin-dependent diabetes mellitus of Otsuka Long-Evans Tokushima\nFatty rats","volume":"35","author":"Mizushige","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"2026081110085328400_cit49","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1210\/jcem.83.3.4668-1","article-title":"Another potential\nuse of troglitazone in noninsulin-dependent diabetes mellitus","volume":"83","author":"Minamikawa","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2026081110085328400_cit50","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/0091270009335768","article-title":"Safety, pharmacokinetics,\nand pharmacodynamics of single doses of LXR-623, a novel liver X-receptor\nagonist, in healthy participants","volume":"49","author":"Katz","year":"2009","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"2026081110085328400_cit51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jphs.2021.11.005","article-title":"ABCA1 and\nABCG1 as potential therapeutic targets for the prevention of atherosclerosis","volume":"148","author":"Matsuo","year":"2022","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"2026081110085328400_cit52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1172\/JCI0215387","article-title":"Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency\nhas a hypercholesterolemic phenotype","volume":"110","author":"Pullinger","year":"2002","journal-title":"J. Clin.\nInvest."},{"issue":"1","key":"2026081110085328400_cit53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pop.2012.11.003","article-title":"Hyperlipidemia\nas a risk factor for cardiovascular disease","volume":"40","author":"Nelson","year":"2013","journal-title":"Prim. Care"},{"issue":"4","key":"2026081110085328400_cit54","doi-asserted-by":"publisher","DOI":"10.1093\/eep\/dvx017","article-title":"Epigenetic impact of endocrine disrupting\nchemicals on lipid homeostasis\nand atherosclerosis: a pregnane X receptor-centric view","volume":"3","author":"Helsley","year":"2017","journal-title":"Environ. Epigenet."},{"issue":"12","key":"2026081110085328400_cit55","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/bph.15433","article-title":"Activation of pregnane\nX receptor induces atherogenic\nlipids and PCSK9 by a SREBP2-mediated mechanism","volume":"178","author":"Karpale","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"2026081110085328400_cit56","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1038\/ncomms10425","article-title":"Modelling the Tox21 10 K chemical profiles\nfor in vivo toxicity prediction and mechanism characterization","volume":"7","author":"Huang","year":"2016","journal-title":"Nat. Commun."},{"key":"2026081110085328400_cit57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.tox.2013.12.005","article-title":"Protective\nrole of cytochrome P450 1A1 (CYP1A1) against benzo[a]pyrene-induced\ntoxicity in mouse aorta","volume":"316","author":"Uno","year":"2014","journal-title":"Toxicology"},{"issue":"1","key":"2026081110085328400_cit58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1097-2765(01)00164-2","article-title":"A PPAR\u03b3-LXR-ABCA1\npathway in macrophages is involved in cholesterol efflux and atherogenesis","volume":"7","author":"Chawla","year":"2001","journal-title":"Mol. Cell"},{"issue":"8","key":"2026081110085328400_cit59","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1043-2760(02)00668-9","article-title":"Peroxisome proliferator-activated\nreceptor-\u03b3\nin macrophage lipid homeostasis","volume":"13","author":"Lee","year":"2002","journal-title":"Trends Endocrinol.\nMetab."},{"issue":"8","key":"2026081110085328400_cit60","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","article-title":"Liver X receptors in lipid signalling\nand membrane\nhomeostasis","volume":"14","author":"Wang","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"2026081110085328400_cit61","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cmet.2005.01.002","article-title":"ABCG1\nhas a critical role in mediating cholesterol efflux to HDL and preventing\ncellular lipid accumulation","volume":"1","author":"Kennedy","year":"2005","journal-title":"Cell Metab."},{"issue":"26","key":"2026081110085328400_cit62","doi-asserted-by":"publisher","first-page":"23742","DOI":"10.1074\/jbc.M102348200","article-title":"ATP-binding cassette\ntransporter A1 (ABCA1) functions as a cholesterol efflux regulatory\nprotein","volume":"276","author":"Wang","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"21","key":"2026081110085328400_cit63","doi-asserted-by":"publisher","first-page":"15013","DOI":"10.1074\/jbc.M511116200","article-title":"A novel pregnane X receptor-mediated\nand sterol regulatory element-binding protein-independent lipogenic\npathway","volume":"281","author":"Zhou","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"2026081110085328400_cit64","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1582-4934.2009.00997.x","article-title":"FXR an emerging therapeutic\ntarget for the treatment\nof atherosclerosis","volume":"14","author":"Mencarelli","year":"2010","journal-title":"J. Cell Mol. Med."},{"key":"2026081110085328400_cit65","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.biopha.2018.07.025","article-title":"Histamine\nH1 type receptor antagonist loratadine ameliorates oxidized LDL induced\nendothelial dysfunction","volume":"106","author":"Zhou","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"36","key":"2026081110085328400_cit66","doi-asserted-by":"publisher","first-page":"34268","DOI":"10.1074\/jbc.M300043200","article-title":"Liver peroxisome proliferator-activated\nreceptor \u03b3 contributes to hepatic steatosis, triglyceride clearance,\nand regulation of body fat mass","volume":"278","author":"Gavrilova","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"34","key":"2026081110085328400_cit67","doi-asserted-by":"publisher","first-page":"13656","DOI":"10.1073\/pnas.1203218109","article-title":"Nuclear receptor PPAR\u03b3-regulated\nmonoacylglycerol O-acyltransferase 1 (MGAT1) expression\nis responsible for the lipid accumulation in diet-induced hepatic\nsteatosis","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"2026081110085328400_cit68","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1172\/JCI59817","article-title":"Liver LXR\u03b1 expression\nis crucial for whole body cholesterol homeostasis and reverse cholesterol\ntransport in mice","volume":"122","author":"Zhang","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"6","key":"2026081110085328400_cit69","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption\nof the nuclear receptor FXR\/BAR\nimpairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"issue":"4","key":"2026081110085328400_cit70","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1074\/jbc.M209525200","article-title":"The farnesoid X-receptor is an essential\nregulator of cholesterol homeostasis","volume":"278","author":"Lambert","year":"2003","journal-title":"J. Biol.\nChem."},{"issue":"2","key":"2026081110085328400_cit71","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/toxsci\/kfs211","article-title":"Chronic exposure\nto rifaximin causes hepatic steatosis in pregnane X receptor-humanized\nmice","volume":"129","author":"Cheng","year":"2012","journal-title":"Toxicol. Sci."},{"key":"2026081110085328400_cit72","doi-asserted-by":"publisher","first-page":"116577","DOI":"10.1016\/j.ecoenv.2024.116577","article-title":"Assessment\nof the disruption effects\nof tetrabromobisphenol A and its analogues on lipid metabolism using\nmultiple in vitro models","volume":"280","author":"Li","year":"2024","journal-title":"Ecotoxicol.\nEnviron. Saf."},{"key":"2026081110085328400_cit73","doi-asserted-by":"publisher","first-page":"111527","DOI":"10.1016\/j.ecoenv.2020.111527","article-title":"Tetrachlorobisphenol\nA induced immunosuppression and uterine injury in mice","volume":"207","author":"Wang","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"2026081110085328400_cit74","doi-asserted-by":"publisher","first-page":"153759","DOI":"10.1016\/j.tox.2024.153759","article-title":"Exposure to\nTCBPA stimulates\nthe growth of arterial smooth muscle cells through the activation\nof the ROS\/NF-\u03baB\/NLRP3 signaling pathway","volume":"503","author":"Qiao","year":"2024","journal-title":"Toxicology"},{"key":"2026081110085328400_cit75","doi-asserted-by":"publisher","first-page":"144960","DOI":"10.1016\/j.scitotenv.2021.144960","article-title":"Ecotoxicity and biodegradation of\nthe bacteriostatic 3,3\u2032,4\u2032,5-tetrachlorosalicylanilide\n(TSCA) compared to the structurally similar bactericide triclosan","volume":"769","author":"Gatidou","year":"2021","journal-title":"Sci. Total Environ."},{"key":"2026081110085328400_cit76","unstructured":"European Chemicals Agency (ECHA).\n          .  4,4\u2032-Methylenebis(2,6-diethylaniline); ECHA: Helsinki,\nFinland, 2025; https:\/\/echa.europa.eu\/substance-information\/-\/substanceinfo\/100.100.398 (accessed Dec 16, 2025)."},{"issue":"18","key":"2026081110085328400_cit77","doi-asserted-by":"publisher","first-page":"11424","DOI":"10.1021\/acs.est.0c02639","article-title":"Structures\nof Endocrine-Disrupting Chemicals Determine Binding to and Activation\nof the Estrogen Receptor \u03b1 and Androgen Receptor","volume":"54","author":"Tan","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"2026081110085328400_cit78","doi-asserted-by":"publisher","first-page":"113962","DOI":"10.1016\/j.envpol.2020.113962","article-title":"Tris(4-hydroxyphenyl)ethane\n(THPE), a trisphenol compound,\nis antiestrogenic and can retard uterine development in CD-1 mice","volume":"260","author":"Xiao","year":"2020","journal-title":"Environ. Pollut."},{"key":"2026081110085328400_cit79","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.chemosphere.2018.02.105","article-title":"LC-MS\/MS determination\nof antiretroviral drugs in influents and effluents from wastewater\ntreatment plants in KwaZulu-Natal, South Africa","volume":"200","author":"Abafe","year":"2018","journal-title":"Chemosphere"},{"issue":"14","key":"2026081110085328400_cit80","doi-asserted-by":"publisher","first-page":"8503","DOI":"10.1021\/acs.est.0c03105","article-title":"Potential emergence of antiviral-resistant\npandemic viruses via environmental drug exposure of animal reservoirs","volume":"54","author":"Kumar","year":"2020","journal-title":"Environ. Sci. Technol."},{"issue":"5","key":"2026081110085328400_cit81","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jhep.2018.12.038","article-title":"Non-nucleoside reverse\ntranscriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia\nand hepatic steatosis","volume":"70","author":"Gwag","year":"2019","journal-title":"J. Hepatol."},{"issue":"4","key":"2026081110085328400_cit82","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2174\/138620711795222446","article-title":"Two panels\nof steroid\nreceptor luciferase reporter cell lines for compound profiling","volume":"14","author":"Sedla\u0301k","year":"2011","journal-title":"Comb. Chem. High Throughput Screen"},{"issue":"4","key":"2026081110085328400_cit83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117125","article-title":"Current\nEfavirenz (EFV) or ritonavir-boosted lopinavir (LPV\/r) use correlates\nwith elevate markers of atherosclerosis in HIV-infected subjects in\nAddis Ababa, Ethiopia","volume":"10","author":"Gleason","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"2026081110085328400_cit84","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3851\/IMP2752","article-title":"Impact of darunavir, atazanavir and\nlopinavir boosted\nwith ritonavir on cultured human endothelial cells: beneficial effect\nof pravastatin","volume":"19","author":"Auclair","year":"2014","journal-title":"Antivir. Ther."},{"issue":"20","key":"2026081110085328400_cit85","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1056\/NEJMoa074609","article-title":"Class-Sparing Regimens\nfor Initial Treatment of HIV-1 Infection","volume":"358","author":"Riddler","year":"2008","journal-title":"N.\nEngl. J. Med."},{"key":"2026081110085328400_cit86","unstructured":"U.S. Food and Drug Administration (FDA).\n          .  KALETRA (lopinavir and ritonavir)\nPrescribing Information; AbbVie LTD; FDA: Silver Spring, MD, 2016; https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/021251s052_021906s046lbl.pdf (accessed Dec 17, 2025)."},{"key":"2026081110085328400_cit87","unstructured":"U.S. Food and Drug Administration (FDA).\n          .  SUSTIVA (efavirenz) Prescribing\nInformation; Bristol-Myers Squibb Company; FDA: Silver Spring, MD, 2016; https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/020972s049-021360s038lbl.pdf (accessed Dec 17, 2025)."},{"issue":"1","key":"2026081110085328400_cit88","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/030006058801600106","article-title":"The pharmacokinetics\nof loratadine in normal geriatric volunteers","volume":"16","author":"Hilbert","year":"1988","journal-title":"J. Int. Med. Res."},{"issue":"7","key":"2026081110085328400_cit89","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/chromsci\/bms048","article-title":"Simultaneous\nquantitation of HIV-protease inhibitors ritonavir, lopinavir and indinavir\nin human plasma by UPLC-ESI-MS-MS","volume":"50","author":"Mishra","year":"2012","journal-title":"J. Chromatogr.\nSci."},{"issue":"11","key":"2026081110085328400_cit90","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/bmc.2696","article-title":"Simultaneous analysis of mitotane and its main metabolites\nin human blood and urine samples by SPE-HPLC technique","volume":"26","author":"Mornar","year":"2012","journal-title":"Biomed. Chromatogr."},{"issue":"2","key":"2026081110085328400_cit91","doi-asserted-by":"publisher","first-page":"H479","DOI":"10.1152\/ajpheart.00817.2003","article-title":"Cardiovascular\npathophysiology of environmental pollutants","volume":"286","author":"Bhatnagar","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"2026081110085328400_cit92","first-page":"40","article-title":"Pathogenesis\nof atherosclerosis: A multifactorial process","volume":"7","author":"Singh","year":"2002","journal-title":"Exp. Clin. Cardiol."},{"issue":"11","key":"2026081110085328400_cit93","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1161\/CIRCULATIONAHA.112.001214","article-title":"Macrophage gene expression and foam\ncell formation are regulated by plasminogen","volume":"127","author":"Das","year":"2013","journal-title":"Circulation"},{"issue":"9","key":"2026081110085328400_cit94","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/nu16091321","article-title":"Naringin inhibits macrophage\nfoam cell formation by regulating lipid homeostasis and metabolic\nphenotype","volume":"16","author":"Liu","year":"2024","journal-title":"Nutrients"},{"issue":"19","key":"2026081110085328400_cit95","doi-asserted-by":"publisher","first-page":"12142","DOI":"10.1021\/acs.est.0c03375","article-title":"Harmonized cross-species assessment of\nendocrine and metabolic disruptors by Ecotox FACTORIAL assay","volume":"54","author":"Medvedev","year":"2020","journal-title":"Environ. Sci. Technol."},{"issue":"1","key":"2026081110085328400_cit96","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1021\/envhealth.4c00172","article-title":"Burnt plastic (pyroplastic) from the M\/V X-Press Pearl ship fire and plastic spill contain compounds\nthat activate endocrine and metabolism-related human and fish transcription\nfactors","volume":"3","author":"James","year":"2025","journal-title":"Environ. Health"}],"container-title":["Environmental Science &amp;\nTechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.est.6c06583","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/esthag\/article-pdf\/60\/31\/21596\/66286731\/acs.est.6c06583.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/esthag\/article-pdf\/60\/31\/21596\/66286731\/acs.est.6c06583.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:01:45Z","timestamp":1786460505000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/esthag\/article\/60\/31\/21596\/5234350\/From-Exposome-Scale-Screening-to-Foam-Cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":96,"journal-issue":{"issue":"31","published-online":{"date-parts":[[2026,7,27]]},"published-print":{"date-parts":[[2026,8,11]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.est.6c06583","relation":{},"ISSN":["0013-936X","1520-5851"],"issn-type":[{"value":"0013-936X","type":"print"},{"value":"1520-5851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]}}}